TC Biopharm (NASDAQ:TCBP) Stock Price Down 2%

TC Biopharm (Holdings) Plc (NASDAQ:TCBP)’s stock price dropped 2% during mid-day trading on Thursday . The company traded as low as $1.43 and last traded at $1.45. Approximately 44,352 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 3,492,144 shares. The stock had previously closed at $1.48.

TC Biopharm Stock Up 0.7 %

The company has a 50 day moving average of $1.48 and a 200 day moving average of $13.42. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.56.

TC Biopharm Company Profile

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers.